Please fill this field

Health Technology Assessment

ENVI
© Image used under the license from Shutterstock.com

On 31 January 2018, the European Commission published its proposal for a “Regulation on health technology assessment” (HTA). The proposal aims to consolidate cooperation among Member States for assessing health technologies. It covers new medicines and certain new medical devices. The proposal addresses amongst others, fragmented approaches from HTA agencies, which may have a negative effect on R&D investment in Europe.

On 14 February 2019, the European Parliament adopted its legislative resolution at first reading. In September 2019, the EP decided not to change the legislative resolution adopted under the previous legislature and appointed Tiemo WÖLKEN (S&D) as Rapporteur (he replaced Soledad CABEZÓN RUIZ (S&D)).

The amended text stipulated that HTA shall be used to promote innovations that produce the best results for patients and society in general. A coordination group composed of representatives from Member States' health technology assessment authorities and bodies should be established with responsibility and proven expertise for overseeing the carrying out of joint clinical assessments and other joint work within the scope of this Regulation.

Rapporteur: T. WÖLKEN (S&D)

Shadows: Nathalie Colin-Oesterlé (EPP), Veronique TRILLET-LENOIR (RE), Michèle RIVASI (Greens), Joelle MELIN (ID), Joanna KOPCINSKA (ECR), Kateřina KONEČNÁ (GUE/NGL)